Detalles de la búsqueda
1.
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.
Int J Cancer
; 145(7): 1970-1981, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30807643
2.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Br J Cancer
; 117(12): 1777-1786, 2017 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123263
3.
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mol Cancer
; 13: 237, 2014 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25331979
4.
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial.
BMC Med
; 17(1): 8, 2019 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621698
5.
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey.
Clin Transl Oncol
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653928
6.
Dual inhibition of MEK and PI3Kß/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.
Front Pharmacol
; 15: 1331648, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318136
7.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Eur Urol Oncol
; 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429210
8.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447275
9.
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer.
Prostate
; 73(5): 512-21, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23038213
10.
Molecular biology of castration-resistant prostate cancer: basis for the novel therapeutic targets.
Arch Esp Urol
; 66(5): 453-62, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23793763
11.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
J Natl Cancer Inst
; 115(3): 332-336, 2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36576009
12.
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab.
JAMA Oncol
; 9(6): 835-840, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103927
13.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Nat Commun
; 14(1): 1157, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859416
14.
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
JAMA Oncol
; 9(6): 841-846, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103916
15.
Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
BJU Int
; 110(9): 1310-6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22416928
16.
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer.
EBioMedicine
; 75: 103801, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990895
17.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230681
18.
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes.
Cancers (Basel)
; 13(19)2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638444
19.
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study.
Eur J Cancer
; 152: 49-59, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077818
20.
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Eur Urol
; 79(6): 722-733, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33153817